Moderately bullish activity in Novo Nordisk (NVO), with shares up $1.18, or 2.31%, near $52.05. Options volume roughly in line with average with 33k contracts traded and calls leading puts for a put/call ratio of 0.31, compared to a typical level near 0.44. Implied volatility (IV30) is higher by 1.4 points near 38.3,in the bottom quartile of the past year, suggesting an expected daily move of $1.26. Put-call skew steepened, indicating increased demand for downside protection.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Pfizer (PFE) Tops List as Drugmakers Plan Price Hike on 350 Medications
- Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
- Novo cuts listing prices for Wegovy in some Chinese provinces, Bloomberg says
- Novo Nordisk Soars as Wegovy Pill Changes the Game
- GLP-1 Pills Gain Ground: Novo Nordisk Wins FDA Nod as Food Giants Tweak Strategy